U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07684846) titled 'Longitudinal Plasma Proteomic Remodeling in Ovarian Cancer' on June 01.
Brief Summary: This longitudinal observational study investigates treatment-associated changes in the circulating plasma proteome of patients with ovarian cancer undergoing standard treatment. Although CA125 and HE4 are established biomarkers for monitoring treatment response, they provide only a limited view of the complex biological processes occurring during therapy.
The study includes patients with epithelial ovarian cancer and primary peritoneal Mullerian tumors who underwent surgery and/or platinum-based chemotherapy. Plasma samples were collected at three...